For 20 years, BIOCORP has been designing, developing and manufacturing medical devices for the pharmaceutical industry, enhancing drug reconstitution, safety, packaging and delivery.
Today, Biocorp continues to innovate in medical plastics, bringing new solutions to the market such as NewGuard, an integrated passive safety system for PFS compatible with existing Nest & Tubs, and Biopass, a reconstitution system with an integrated needle ready to inject.
Recognised for its expertise in device R&D, Biocorp has incorporated software development capacities to develop connected drug delivery systems, including Datapen, a reusable smart pen injector that automatically transmits data to a treatment mobile app, helping patients to manage their treatment; and a range of add-ons including smart sensors for existing drug delivery devices (pen injectors, MDIs). Our innovative connected products have won multiple awards: Pharmapack 2015, Pharmapack 2016, Frost & Sullivan 2016, E-health summer University 2017 and CPhI award 2017.
On top of R&D capacities, BIOCORP also provides manufacturing services for plastic injection, process assembly and blister packaging.
Connected drug delivery systems are smart medical devices designed to meet patients' evolving needs and healthcare providers' new requirements for efficient, connected and user-friendly health solutions. Our main objective is to support patients in their fight against chronic diseases (diabetes, BPCO, asthma, multiple sclerosis, Parkinson's disease, infertility, etc).
Our experienced engineers offer electronics, mechanical, software and firmware expertise to handle the challenges of designing and developing connected medical devices.
Biocorp has developed a multi-award-winning range of connected drug delivery systems such as Datapen, a connected reusable pen injector for chronic diseases treatment; Easylog, a smart sensor that connects all pen injectors and captures exact dose with 100% accuracy, and Inspair, a smart sensor that connects all inhalers and captures key treatment information.
Biocorp is a proven expert in the design and manufacture of pharmaceutical drug delivery systems. Our portfolio of proprietary products is composed of safety systems, reconstitution systems and closure systems.
Biocorp has developed a range of pharmaceutical devices including NewGuard, an integrated passive safety system for prefilled syringes (PFS); Biopass, an innovative and user-friendly device that enables the convenient reconstitution of lyophilised drugs, and Newseal, a closure system compatible with standard vials that avoids aluminium crimping.
Continuing to bring innovative solutions for our customers, our design and development team is committed to providing you with the expertise needed to initiate a new product development programme.
Biocorp serves different markets in France and abroad, our main customers being pharmaceutical, veterinary and diagnostic companies. We are fully dedicated and structured to answer your requirements and provide you with all necessary certificates for our collaboration.
Our expertise in products developments and our robust R&D process lead us to develop customised solution for our customers and packaging partners. We can support our contract manufacturing to develop and produce simple packaging such as spoons, droppers, colutary devices, dosing pipettes, tubes and caps. We also manage the complete development process from FTO (free to operate) analysis to functional prototype based on our technology platforms or from customer URS.
To discover more about our offering, complete the enquiry form below.